CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Genotype-Guided Strategy for Oral P2Y12 Inhibitors Cholesterol-Lowering Agents A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association Management of No-Reflow Phenomenon in the Catheterization Laboratory Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients Advances in Coronary No-Reflow Phenomenon-a Contemporary Review Association Between Living in Food Deserts and Cardiovascular Risk

Recommandation StatementFeb 13, 2020

JOURNAL:ACC Article Link

ACC Clinical Bulletin Focuses on Cardiac Implications of Coronavirus (COVID-19)

ACC Keywords: COVID-19;

FULL TEXT PDF